Generic Biologics May See Life After PDUFA; Senate Mark-Up Possible In May

Leadership of the Senate Health Committee remains committed to creating a pathway for follow-on biologics, despite the fact that language was not included in an omnibus FDA bill passed out of committee April 18

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet